Sintx Technologies Announces Board Chairman Transition

SALT LAKE CITY, Utah, March 17, 2025 (GLOBE NEWSWIRE) -- Sintx Technologies, Inc. (NASDAQ: SINT) (“Sintx” or the “Company”), a leader in advanced ceramics for medical device and technical applications, today announced that Dr. Sonny Bal has retired as Chairman of the Board, and the Board of Directors has unanimously appointed Eric Olson, the Company’s Chief Executive Officer, as its new Chairman, effective immediately.

Dr. Bal, who has served as Chairman since 2015, has played a crucial role in driving Sintx’s transformation, strengthening its core business, and positioning the Company for growth in the advanced materials sectors. He will continue to support the Company as a member of the Board of Directors, ensuring continuity as Sintx executes on its strategic objectives.

“On behalf of the Board and the entire Sintx team, I want to thank Sonny for his years of leadership, vision, and commitment to innovation,” said Eric Olson, CEO and newly appointed Chairman. “His guidance has helped prepare Sintx’s transition toward high-value medical applications and strategic partnerships. As we move into the next phase of execution, I am excited to lead the Company in advancing our commercial strategy, optimizing our asset portfolio, and delivering long-term value to our shareholders.”

Dr. Bal commented, “It has been an honor to serve as Chairman of Sintx Technologies and work alongside such a talented team. I am confident that under Eric’s leadership, Sintx is well-positioned for the next stage of growth, with a clear focus on unlocking the full potential of its biomaterial technology platform.”

Since being appointed CEO in August 2024, Eric Olson has refocused the Company on high-growth opportunities in biomedical and medical device applications. With a proven track record of leadership in the medical device and industrial sectors, his appointment as Chairman reinforces Sintx’s commitment to accelerating commercialization, enhancing financial discipline, and exploring strategic initiatives, including partnerships, licensing, and M&A opportunities.

For more information, please visit

About SINTX Technologies, Inc.

Located in Salt Lake City, Utah, SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Over the past several years, SINTX has utilized strategic acquisitions and alliances to enter into new markets. For more information on SINTX Technologies or its materials platform, visit .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”) that are subject to a number of risks and uncertainties. Forward-looking statements can be identified by words such as: "anticipate," "believe," "project," "estimate," "expect," "strategy,” "future," "likely," "may," "should," "will" and similar references to future periods.

Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, difficulty in commercializing ceramic technologies and development of new product opportunities. A discussion of other risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the SEC on March 27, 2024, and in SINTX’s other filings with the SEC. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report, except as required by law.

Business and Media Inquiries for SINTX:

SINTX Technologies

801.839.3502